Palvella Therapeutics, Inc. (PVLA)
138.96
+7.62
(+5.80%)
USD |
NASDAQ |
Oct 09, 16:00
138.96
0.00 (0.00%)
After-Hours: 20:00
Palvella Therapeutics Market Cap : 2.000B for Oct. 9, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 08, 2026 | 1.891B |
| October 07, 2026 | 1.880B |
| October 06, 2026 | 1.843B |
| October 05, 2026 | 1.903B |
| October 02, 2026 | 1.907B |
| October 01, 2026 | 1.911B |
| September 30, 2026 | 1.986B |
| September 29, 2026 | 2.001B |
| September 28, 2026 | 2.013B |
| September 25, 2026 | 1.989B |
| September 24, 2026 | 2.103B |
| September 23, 2026 | 2.153B |
| September 22, 2026 | 2.276B |
| September 21, 2026 | 2.208B |
| September 18, 2026 | 2.167B |
| September 17, 2026 | 2.222B |
| September 16, 2026 | 2.180B |
| September 15, 2026 | 2.177B |
| September 14, 2026 | 2.184B |
| September 11, 2026 | 2.161B |
| September 10, 2026 | 2.165B |
| September 09, 2026 | 2.179B |
| September 08, 2026 | 2.192B |
| September 04, 2026 | 2.264B |
| September 03, 2026 | 2.238B |
| Date | Value |
|---|---|
| September 02, 2026 | 2.202B |
| September 01, 2026 | 2.167B |
| August 31, 2026 | 2.197B |
| August 28, 2026 | 2.159B |
| August 27, 2026 | 2.164B |
| August 26, 2026 | 2.222B |
| August 25, 2026 | 2.134B |
| August 24, 2026 | 2.098B |
| August 21, 2026 | 2.045B |
| August 20, 2026 | 2.053B |
| August 19, 2026 | 2.159B |
| August 18, 2026 | 2.165B |
| August 17, 2026 | 2.210B |
| August 14, 2026 | 2.248B |
| August 13, 2026 | 2.254B |
| August 12, 2026 | 2.232B |
| August 11, 2026 | 2.221B |
| August 10, 2026 | 2.191B |
| August 07, 2026 | 2.271B |
| August 06, 2026 | 2.230B |
| August 05, 2026 | 2.217B |
| August 04, 2026 | 2.176B |
| August 03, 2026 | 2.015B |
| July 31, 2026 | 1.990B |
| July 30, 2026 | 2.150B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Agenus, Inc. | 326.22M |
| Amgen, Inc. | 224.24B |
| BioCryst Pharmaceuticals, Inc. | 2.185B |
| Imunon, Inc. | 5.039M |
| Curis, Inc. | 1.300M |
Market Cap Related Metrics
| Price to Book Value | 9.224 |
| Price | 138.96 |
| Earnings Yield | -3.48% |